文献速递重症综合管理与镇静镇痛心脑血管急症

较低的血糖目标与心脏及心胸外科患者30天死亡率改善相关

Lower Glucose Target Is Associated With Improved 30-Day Mortality in Cardiac and Cardiothoracic Patients.
PubMed 文献 · Chest · 2018-04-26
一句话结论在严重低血糖发生率极低的心脏ICU中,采用80-110 mg/dL血糖目标与30天死亡率降低相关(OR 0.65),但作者认为目前不应据此指导临床实践。

该研究在主要收治心脏ICU患者的队列中,比较两种静脉胰岛素血糖目标(80-110 vs 90-140 mg/dL)对30天死亡率的影响。共纳入1809例接受静脉胰岛素治疗的危重患者,采用倾向性评分校正回归分析。80-110 mg/dL组中位血糖更低(104 vs 122 mg/dL,P < .001),两组严重低血糖发生率均极低(1.16% vs 0.35%,P = .051)。未校正30天死亡率在80-110 mg/dL组更低(4.3% vs 9.2%,P < .001),倾向性评分校正后仍显著(OR 0.65;95% CI 0.43-0.98;P = .04)。作者结论认为严格血糖控制可在低严重低血糖率下实现并与死亡率降低相关,但目前不应据此指导临床实践,需在低严重低血糖方案下重新审视严格血糖控制。

要点

  • 在主要收治心脏ICU的危重患者中,80-110 mg/dL血糖目标与30天死亡率降低独立相关(校正OR 0.65;95% CI 0.43-0.98;P = .04)。
  • 80-110 mg/dL组中位血糖104 mg/dL,90-140 mg/dL组122 mg/dL(P < .001)。
  • 严重低血糖发生率在80-110 mg/dL组为1.16%,90-140 mg/dL组为0.35%(P = .051)。
  • 未校正30天死亡率80-110 mg/dL组4.3%,90-140 mg/dL组9.2%(P < .001)。
  • 作者认为目前不应以该结果指导临床实践,严格血糖控制需在低严重低血糖方案下重新审视。

适用人群与场景

  • 接受静脉胰岛素治疗的成年危重患者,主要收治于心脏ICU。

诊断标准与关键阈值

  • 静脉胰岛素血糖目标分为80-110 mg/dL与90-140 mg/dL两组。

处置流程与药物剂量

  • 使用计算机化静脉胰岛素方案,允许选择血糖目标80-110 mg/dL或90-140 mg/dL。

研究设计与关键结果

  • 研究类型为队列研究,共纳入1809例符合纳入标准的患者;基线特征相似。
  • 80-110 mg/dL组中位血糖104 mg/dL,90-140 mg/dL组122 mg/dL(P < .001)。
  • 严重低血糖发生率80-110 mg/dL组1.16%,90-140 mg/dL组0.35%(P = .051)。
  • 未校正30天死亡率80-110 mg/dL组4.3%,90-140 mg/dL组9.2%(P < .001)。
  • 倾向性评分校正回归分析显示,80-110 mg/dL组30天死亡率低于90-140 mg/dL组(OR 0.65;95% CI 0.43-0.98;P = .04)。

证据类型、等级与局限

  • 证据类型为队列研究,采用倾向性评分校正回归分析。
  • 作者结论指出,当前不应以该发现指导临床实践,严格血糖控制需在低严重低血糖方案下重新审视。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,目前不应以该研究结果指导临床实践。
  • 作者建议,应在严重低血糖发生率低的方案下重新审视严格血糖控制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Practice guidelines recommend against intensive insulin therapy in patients who are critically ill based on trials that had high rates of severe hypoglycemia. Intermountain Healthcare uses a computerized IV insulin protocol that allows choice of blood glucose (BG) targets (80-110 vs 90-140 mg/dL) and has low rates of severe hypoglycemia. We sought to study the effects of BG target on mortality in adult patients in cardiac ICUs that have very low rates of severe hypoglycemia.

METHODS: Critically ill patients receiving IV insulin were treated with either of two BG targets (80-110 vs 90-140 mg/dL). We created a propensity score for BG target using factors thought to have influenced clinicians' choice, and then we performed a propensity score-adjusted regression analysis for 30-day mortality.

RESULTS: There were 1,809 patients who met inclusion criteria. Baseline patient characteristics were similar. Median glucose was lower in the 80-110 mg/dL group (104 vs 122 mg/dL, P < .001). Severe hypoglycemia occurred at very low rates in both groups (1.16% vs 0.35%, P = .051). Unadjusted 30-day mortality was lower in the 80-110 mg/dL group (4.3% vs 9.2%, P < .001). This remained after propensity score-adjusted regression (OR, 0.65; 95% CI, 0.43-0.98; P = .04).

CONCLUSIONS: Tight glucose control can be achieved with low rates of severe hypoglycemia and is associated with decreased 30-day mortality in a cohort of largely patients in cardiac ICUs. Although such findings should not be used to guide clinical practice at present, the use of tight glucose control should be reexamined using a protocol that has low rates of severe hypoglycemia.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Hersh AM, Hirshberg EL, Wilson EL, et al. Lower Glucose Target Is Associated With Improved 30-Day Mortality in Cardiac and Cardiothoracic Patients. Chest. 2018. PMID: 29705217. doi:10.1016/j.chest.2018.04.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。